Jin‐Hua Liang

1.6k total citations
105 papers, 1.0k citations indexed

About

Jin‐Hua Liang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Jin‐Hua Liang has authored 105 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pathology and Forensic Medicine, 48 papers in Oncology and 34 papers in Genetics. Recurrent topics in Jin‐Hua Liang's work include Lymphoma Diagnosis and Treatment (78 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Viral-associated cancers and disorders (31 papers). Jin‐Hua Liang is often cited by papers focused on Lymphoma Diagnosis and Treatment (78 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Viral-associated cancers and disorders (31 papers). Jin‐Hua Liang collaborates with scholars based in China, Netherlands and United Kingdom. Jin‐Hua Liang's co-authors include Jianyong Li, Wei Xu, Lei Fan, Huayuan Zhu, Jia‐Zhu Wu, Yi Xia, Lei Cao, Li Wang, Li Wang and Wei Wu and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jin‐Hua Liang

96 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Hua Liang China 18 486 413 243 222 208 105 1.0k
William W.L. Choi United States 13 426 0.9× 352 0.9× 229 0.9× 131 0.6× 306 1.5× 18 1.1k
Ana Ferrer Spain 21 609 1.3× 472 1.1× 417 1.7× 192 0.9× 258 1.2× 79 1.5k
Dimitra Rontogianni Greece 22 478 1.0× 464 1.1× 201 0.8× 178 0.8× 225 1.1× 88 1.4k
Jean Pierre Marolleau France 17 397 0.8× 324 0.8× 191 0.8× 221 1.0× 198 1.0× 53 977
Markus Tiemann Germany 17 230 0.5× 407 1.0× 83 0.3× 248 1.1× 177 0.9× 73 959
Hirotaka Takasaki Japan 16 317 0.7× 244 0.6× 148 0.6× 131 0.6× 80 0.4× 59 732
Qin Huang United States 16 245 0.5× 238 0.6× 263 1.1× 173 0.8× 220 1.1× 62 887
Ronald Reimer United States 20 484 1.0× 487 1.2× 166 0.7× 57 0.3× 212 1.0× 45 1.7k
Heidi D. Finnes United States 15 198 0.4× 693 1.7× 305 1.3× 224 1.0× 135 0.6× 37 1.0k
John Amess United Kingdom 12 619 1.3× 445 1.1× 358 1.5× 130 0.6× 246 1.2× 16 1.3k

Countries citing papers authored by Jin‐Hua Liang

Since Specialization
Citations

This map shows the geographic impact of Jin‐Hua Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Hua Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Hua Liang more than expected).

Fields of papers citing papers by Jin‐Hua Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Hua Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Hua Liang. The network helps show where Jin‐Hua Liang may publish in the future.

Co-authorship network of co-authors of Jin‐Hua Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Hua Liang. A scholar is included among the top collaborators of Jin‐Hua Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Hua Liang. Jin‐Hua Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Jin‐Hua, Wei Hua, Hua Yin, et al.. (2025). Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study. Cell Communication and Signaling. 23(1). 441–441.
2.
Wang, Huili, Wei Hua, Rui Gao, et al.. (2025). A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients. Cancer Research and Treatment.
3.
Liang, Jin‐Hua, Yifan Wu, Yue Li, et al.. (2024). Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort. Blood. 144(Supplement 1). 576–576. 1 indexed citations
4.
Wu, Jia‐Zhu, Jin‐Hua Liang, Li Wang, et al.. (2024). Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century. Annals of Hematology. 103(5). 1675–1685. 1 indexed citations
5.
Hua, Wei, Yue Li, Jia‐Zhu Wu, et al.. (2024). Analysis of CCND3 mutations in diffuse large B-cell lymphoma. Annals of Hematology. 103(12). 5729–5739. 3 indexed citations
6.
Liang, Jin‐Hua, Yifan Wu, Yue Li, et al.. (2024). Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia. 38(7). 1541–1552. 6 indexed citations
7.
Wu, Yifan, Qunhui Yuan, Hao Shen, et al.. (2024). The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era. Cancer Science. 116(1). 257–270. 1 indexed citations
8.
Hua, Wei, Jie Liu, Yue Li, et al.. (2024). Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy. Clinical and Translational Medicine. 15(1). e70150–e70150. 2 indexed citations
9.
Wu, Yifan, Hua Wei, Rui Gao, et al.. (2024). Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell Communication and Signaling. 22(1). 401–401.
10.
Zhang, Jing, Qingqing Chen, Yi Xia, et al.. (2023). The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 43(6). 1302–1310. 9 indexed citations
11.
Liang, Jin‐Hua, Yimin Ren, Rui Gao, et al.. (2023). MYC‐induced cytidine metabolism regulates survival and drug resistance via cGas‐STING pathway in mantle cell lymphoma. British Journal of Haematology. 202(3). 550–565. 9 indexed citations
12.
Liu, Lu, Hui Yang, Jin‐Hua Liang, et al.. (2022). BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion. Molecular Cancer. 21(1). 59–59. 38 indexed citations
13.
Cao, Xin, Yilin Kong, Li Wang, et al.. (2021). Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Annals of Hematology. 100(4). 995–1002. 7 indexed citations
14.
Zhou, Xiaohui, Jin‐Hua Liang, Li Wang, et al.. (2020). High viral loads of circulating Epstein-Barr virus DNA copy number in peripheral blood is associated with inferior prognosis in patients with mantle cell lymphoma. Journal of Cancer. 11(17). 4980–4988. 5 indexed citations
15.
Fan, Lei, Jin‐Hua Liang, Robert Peter Gale, et al.. (2018). Definition of disease‐progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological Oncology. 36(4). 656–662. 2 indexed citations
16.
Tian, Tian, Huayuan Zhu, Jin‐Hua Liang, et al.. (2018). Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. Annals of Hematology. 97(10). 1841–1849. 9 indexed citations
17.
Zou, Yixin, Huayuan Zhu, Ruinan Lu, et al.. (2018). Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases. Cancer Research and Treatment. 51(2). 664–671. 22 indexed citations
18.
Yang, Yuqiong, Tian Tian, Huayuan Zhu, et al.. (2018). NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC Cancer. 18(1). 1009–1009. 17 indexed citations
19.
Gao, Rui, Wei Xu, Jin‐Hua Liang, et al.. (2017). Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma. Blood. 130. 2848. 1 indexed citations
20.
Wang, Dong, et al.. (2014). Mild hypothermia combined with a scaffold of NgR-silenced neural stem cells/Schwann cells to treat spinal cord injury. Neural Regeneration Research. 9(24). 2189–2189. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William W.L. Choi Breakdown of academic impact, for papers by Ana Ferrer Breakdown of academic impact, for papers by Dimitra Rontogianni Breakdown of academic impact, for papers by Jean Pierre Marolleau Breakdown of academic impact, for papers by Markus Tiemann Breakdown of academic impact, for papers by Hirotaka Takasaki Breakdown of academic impact, for papers by Qin Huang Breakdown of academic impact, for papers by Ronald Reimer Breakdown of academic impact, for papers by Heidi D. Finnes Breakdown of academic impact, for papers by John Amess
Rankless by CCL
2026